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Use of a carbocyanine dye as a marker of functional vasculature in
murine tumours
M.J. Trotter, D.J. Chaplin & P.L. Olive
Medical Biophysics Unit, BC Cancer Research Centre, 601 West 10th Avenue, Vancouver, BC, Canada V5Z IL3.
Summary An intravenously administered fluorescent carbocyanine dye, DiOC7(3), has been evaluated for
use in conjunction with Hoechst 33342 as a marker of murine tumour vasculature. DiOC7(3) stains cells
immediately adjacent to blood vessels and thus, like Hoechst 33342, outlines perfused tumour vasculature.
The different fluorescence excitation and emission properties of DiOC7(3) and Hoechst 33342 permit
discrimination of the stains in the same tissue section. Mice tolerate a DiOC7(3) dose of 1 mgkg - i.v. with
no ill effects. The dye has a distribution half-life in blood of 180s and staining of perivascular tumour cells is
sufficiently stable to allow visualisation of vasculature for up to 30min after DiOC7(3) injection. However,
DiOC7(3) causes a 75% reduction in tumour blood flow as measured by laser Doppler techniques.
Consequently, the compound appears to be most suitable as a second vascular marker, administered at some
time after Hoechst 33342, to detect temporal and spatial fluctuations in tumour perfusion.
Quantitative histological study of microvascular perfusion in
solid experimental tumours can be undertaken using blood-
borne stains or tracer substances which label the functional
tumour vasculature. Substances confined exclusively to the
vascular compartment, such as 51Cr-labelled red blood cells
and high molecular weight dextrans, have been used to
measure functional tumour vascular space (Gullino &
Grantham, 1964; Tannock & Steel, 1969). Most biological
stains (for example, Evans blue, trypan blue or lissamine
green) penetrate rapidly from blood vessels into the inter-
stitial compartment following injection (Goldacre & Sylven,
1962). Some fluorescent dyes, such as fluorescein, behave
similarly. Thus, unless animals are killed and tumours
removed immediately after stain administration, no
discrimination of tumour vasculature is obtained.
Fluorescent or radiolabelled microspheres can also be used
to label blood vessels but they are trapped in only a small
fraction of tumour vessels seen in thin tissue sections.
However, identification of functional tumour vasculature
can be achieved using intravenously administered dyes which
avidly stain cells adjacent to the blood supply and thus
penetrate slowly into tumour parenchyma. A DNA-binding,
UV light-excited fluorescent stain, Hoechst 33342, has such
properties and has been used to investigate vascular patterns
within tumours (Reinhold & Visser, 1983), for cell selection
from tumours using fluorescence-activated cell sorting
(Chaplin et al., 1985; Olive et al., 1985), and as a vascular
space marker in tumours (Smith et al., 1988).
Regions of tumour microvasculature may be subject to
transient reductions in perfusion, flow stasis, or vascular
collapse (Brown, 1979; Intaglietta et al., 1977; Reinhold et
al., 1977; Chaplin et al., 1986, 1987). Thus, stains such as
Hoechst 33342, with a short half-life in blood, may not
identify tumour vessels which are collapsed or otherwise
non-functional during the few minutes following injection.
Histological detection of such regions might be achieved by
administration of a second vascular marker at some interval
after Hoechst 33342 so that collapsed vessels, if they reopen,
could be visualised. Conversely, cells near vessels which close
during the interval between stain injections would be labelled
only by Hoechst stain and not the second marker.
We have examined a fluorescent carbocyanine derivative,
3,3'-diheptyloxacarbocyanine (DiOC7(3)), for use as a
marker of tumour vasculature. DiOC7(3) has been employed
previously in photographic processing and as a membrane
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potential probe (Sims et al., 1974). The slow penetration rate
of this dye has been used to select cells from different depths
within multicell spheroids (Olive & Durand, 1987). DiOC7(3)
has a long alkyl side chain, increasing its lipophilicity and
facilitating rapid entry into cells. This suggested to us that
this dye might have in vivo staining characteristics similar to
Hoechst 33342; that is, to stain cells immediately adjacent to
blood vessels. Carbocyanine dyes are excited by visible light
and can easily be discriminated from Hoechst 33342 when
both stains are present in tissue sections examined by
fluorescence microscopy. Thus, such dyes, used in conjunc-
tion with Hoechst 33342, could be employed in a double
staining protocol to identify regions of transient perfusion in
experimental tumours.
We have investigated DiOC7(3) for use as a marker of
functional tumour vasculature and have examined
pharmacokinetics, in vivo toxicity, stability of binding to
tumour cells and vasoactive properties of the dye.
Materials and methods
Fluorescent dyes
The carbocyanine dye DiOC7(3) was obtained from
Molecular Probes Inc. (Eugene, OR, USA). The structure of
symmetric carbocyanine dyes is shown in Figure 1 and can
be described using the abbreviated notation DiYCn(2m+1)
(Sims et al., 1974). The lipophilicity of cyanine dyes increases
with n in the above formula and the wavelengths of
maximum absorption and emission increase with m.
DiOC7(3) has a molecular weight of 600 and exhibits green
fluorescence when excited by blue light.
Carbocyanine dyes are poorly soluble in aqueous solution
and DiOC7(3) was dissolved in dimethyl sulphoxide (DMSO)
and then diluted to 75% DMSO with phosphate-buffered
saline before use. Hoechst 33342 (Sigma, St Louis, MO,
USA) was dissolved in sterile phosphate-buffered saline and
administered intravenously at a dose of 15mgkg-1.
Blood levels of DiOC7(3) after i.v. injection were deter-
mined by fluorometric methods as described previously
(Olive et al., 1985). Toxicity of DiOC7(3) towards SCCVII
tumour cells exposed to the stain in vivo was assessed as
follows. Tumours were excised 5min after simultaneous i.v.
administration of Hoechst 33342 and DiOC7(3) (Imgkg-1)
and enzymatically disaggregated into a single cell suspension.
Using a flow cytometer, cells were sorted into 10 fractions
on the basis of the Hoechst 33342 diffusion gradient
(Chaplin et al., 1985) and examined for clonogenicity by
plating in 100-mm plastic tissue culture dishes kept in a
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Figure 1 Blood levels of DiOC7(3) in C3H/He mice following
intravenous injection of 1 mgkg-1. The mean +standard
deviation (s.d.) is shown and for those symbols without s.d. bars,
the s.d. is less than the symbol size.
tumour with little or no contribution from skin or sub-
cutaneous tissue. Red blood cell flux, number of moving
RBCs and mean RBC velocity were continually monitored
both before and after injection of DiOC7(3), 1 mgkg-i.v.
The influence of intravenously injected DiOC7(3) on the
haematocrit of orbital sinus blood samples was also
measured.
Results
Following intravenous administration, the blood concen-
tration of DiOC7(3) declined exponentially with a distri-
bution half-life of 180s (compared to 100s for Hoechst
33342) and an elimination half-life of approximately 30min
(based on a two-compartment model of drug kinetics)
(Figure 1). The apparent volume of distribution of DiOC7(3)
is very large, reflecting the lipophilic nature of the stain.
Mice tolerated an intravenous dose of 1 mgkg-I without
obvious acute ill effects and were alive and well 6 weeks
after drug administration. Doses greater than 5mgkg-1
resulted in death of the animal. The in vitro plating efficiency
of SCCVII tumour cells exposed to DiOC7(3)
(1mgkg-1i.v.) in vivo was not significantly reduced. Even
cells located in the brightest Hoechst 33342 sort fractions,
representing cells closest to tumour blood vessels and thus
exposed to the highest concentration of DiOC7(3), showed
no reduction in clonogenicity (data not shown).
DiOC7(3)-staining of cells immediately adjacent to blood
humidified incubator equilibrated with 5% CO2, 5% 02 and
90% N2. Colonies were stained and counted 12 days later.
Identification of tumour vasculature
The ability of DiOC7(3) to act as a marker of functional
tumour vasculature was examined in SCCVII grown sub-
cutaneously (s.c.) in C3H/He mice. The dye was administered
via lateral tail vein injection at a dose of 1 mgkg-I in 50pi
volume. This dose provided optimal visualisation of tumour
vasculature. Animals were killed by cervical dislocation at
various intervals after dye injection and tumours were
immediately excised and frozen at -20°C in OCT
embedding compound. Frozen sections 10gm in thickness
were rewarmed to room temperature, allowed to air dry, and
examined using a microscope with 100W mercury lamp
illumination and an epifluorescence condenser using 430-
490nm excitation, a 510nm dichroic mirror and a 520nm
long pass filter. Stain stability and bleaching were measured
using an image intensified charge-injection device (CID)
camera linked to a computer-based image processing system
(Jaggi et al., 1988).
Tumour bloodflow measurements
Relative changes in tumour blood flow following intravenous
injection of DiOC7(3) were measured using an infrared laser
Doppler flowmeter (TSI Inc., St Paul, MN, USA). Electrical
signals from the lascr Doppler photodetector are propor-
tional to the number of moving red blood cells (RBCs) and
to mean RBC velocity. RBC flux (expressed as mlmin-m
100g tissue-1) is the product of these two measurements.
This instrument is capable of monitoring tissue micro-
vascular flow continuously and noninvasively with a spatial
resolution of approximately I mm3 (Haumschild, 1986;
Shepherd et al., 1987). Animals bearing s.c. implanted
tumours were anaesthetised with ketamine (50mgkg-li.p.)
and diazepam (IO mgkg- 1 i.p.), a 1-2 mm incision was made
in the thinned skin directly overlying the tumour, and a
0.7 mm diameter laser Doppler needle probe was placed
through this incision on to the tumour. Thus, flow measure-
ments were recorded from a small, peripheral region of
Figure 2 Photomicrographs of a SCCVII tumour frozen section
in which functional blood vessels were marked in vivo by
simultaneous i.v. injection of Hoechst 33342 (upper panel) and
DiOC7(3) (lower panel). The mouse was killed and tumour
removed 5min after stain administration. Hoechst 33342 was
visualised using UV excitation at 376 nm and a 418 nm long pass
barrier filter. Section thickness is 10 lm and the scale bar
represents 20 uim.
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Figure 3 Quantitation of vascularity using DiOC7(3). The
number of stained regions per 1 mm2 is plotted as a function of
tumour weight for 29 subcutaneously implanted SCCVII
tumours. The stain was administered i.v. to unrestrained,
unanaesthetised mice. Counting was restricted to non-necrotic
tumour regions. For each tumour, a total area of approximately
15mm2 was counted. The best fit linear regression line with 95%
confidence limits is shown. The negative correlation is weak
(r=0.67) but statistically significant (P<0.01).
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were injected simultaneously, no significant staining mis-
match (vessels identified by one stain but not the other) was
observed. Hoechst 33342 has been used to estimate tumour
vascular volume (Smith et al., 1988) and similar
morphometric techniques can be employed using DiOC7(3).
Blood vessels outlined by DiOC7(3) staining can be easily
counted in tumour sections. In viable portions of SCCVII
tumours there is a weak negative correlation (r=0.67)
between the density of fluorescently stained regions and
tumour size (Figure 3).
The stability of DiOC7(3) fluorescence in SCCVII tumours
and the localisation of dye in relation to blood vessels were
assessed using the fluorescence imaging system. In the first
few minutes following DiOC7(3) injection, the dye was seen
only in cells located a small distance from the vessel lumen.
With time, dye became detectable in cells more distant from
the blood supply and fluorescence of the perivascular cells
declined; that is, peak fluorescence intensity decreased and
staining distance away from vessel increased. The peak-
fluorescence/distance ratio is therefore a measure of dye
localisation in relation to tumour blood vessels (Figure 4).
Thirty to 60min following DiOC7(3) administration, the
difference in fluorescence intensity between perivascular cells
and cells more distant from the blood supply is essentially
lost. Visualisation of tumour vasculature was most distinct if
tumours were removed 5min after dye injection. DiOC7(3)
fluorescence is relatively resistant to bleaching by continuous
illumination of the tissue section with blue light using our
optical system. In comparison, Hoechst 33342 fluorescence
fades rapidly when excited by UV light.
DiOC7(3) caused a reduction in blood flow in SCCVII
tumours as measured using laser Doppler flowmetry (Figure
5). Baseline values for RBC flux varied between 4.8 and
8.0mlmin-1 lOOg-1 (mean 5.95+1.23). DiOC7(3) injection
resulted in an initial transient reduction, recovery and then a
gradual, significant decline in flux to levels which were
approximately 25% of baseline values (mean 1.58+0.73,
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Figure 4 Stability of DiOC7(3) staining of SCCVII tumour cells
in vivo. Peak fluorescence intensity declined and staining distance
away from vessels increased with time after dye injection. Error
bars represent standard error of the mean (s.e.m.) for 20 vessels
per tumour. Below a fluorescence/distance ratio of about 5,
counting blood vessels was not possible primarily because vessels
near to each other could not be easily discriminated.
vessels allowed identification of perfused vasculature in the
murine SCCVII tumour and similar results have been
obtained in other tumour models used in our laboratory.
The staining pattern is similar to that obtained using
Hoechst 33342 (Figure 2). If Hoechst 33342 and DiOC7(3)
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Figure 5 Effects of DiOC7(3) (1 mgkg- i.v.) on red blood cell
(RBC) flux, number of moving RBCs (indicative of functional
microvascular volume), and mean RBC velocity in subcutaneous
SCCVII tumours as assessed by laser Doppler flowmetry. Error
bars represent s.e.m. for five tumours.
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P<0.001). When alone, 75% DMSO (75%) caused no
changes in tumour blood flow. Intravenous administration of
DiOC7(3) did not alter blood haematocrit. In unanaesthe-
tised animals, DiOC7(3) also caused a slight decrease (1.5°C)
in body temperature.
Discussion
The fluorescent carbocyanine dye, DiOC7(3), rapidly enters
and stains cells immediately adjacent to the blood supply,
thus identifying functional vasculature in murine tumours.
Intravenous administration of either DiOC7(3) or Hoechst
33342 results in similar staining patterns. In conjunction with
Hoechst 33342, DiOC7(3) appears useful as a vascular
marker in double staining experiments designed to locate
regions of transient perfusion in experimental tumours.
Carbocyanine dyes have been used extensively for
measurement of cell membrane potential and DiOC7(3) has
been shown to stain proliferating cells to a greater extent
than non-proliferating cells (Cohen et al., 1981). However,
avid dye uptake by perivascular cells and slow penetration of
DiOC7(3) into tumour parenchyma dominate staining in
vivo. DiOC7(3) can be used for cell selection from multicell
spheroids using fluorescence-activated cell sorting (Olive &
Durand, 1987) but sorting cells from solid tumours on the
basis of DiOC7(3) fluorescence has not, to date, been
successful. The time required for mechanical and enzymatic
dissociation of solid murine tumours into single cell
suspensions and leakage of dye from cells damaged during
disaggregation results in reduction of the large staining
gradient initially present in intact tumours.
DiOC7(3) is strongly fluorescent and if tumours are
removed within 5min of dye injection excellent contrast is
obtained between stained and unstained tumour regions. For
photomicrography or image processing, DiOC7(3) (green
fluorescence) is superior to Hoechst 33342 since CID
cameras and most photographic film are maximally sensitive
to green light. In addition, the dye is relatively resistant to
bleaching thereby allowing prolonged illumination of the
tissue section for vessel counting or fluorescence measure-
ments. DiOC7(3) can be successfully employed as a marker
for functional tumour vasculature provided several
limitations are kept in mind. Firstly, poor solubility requires
the use of an organic solvent to maintain DiOC7(3) in
solution. In our studies, 501I of 75% DMSO solution was
well tolerated by the animal and had no effect on vascular
staining patterns or tumour blood flow. Secondly, although
immediate tumour excision after DiOC7(3) injection is not
necessary for counting of stained regions, tumours should be
removed rapidly, preferably within 5min, since the staining
gradient declines with time. Finally, the dye causes a
significant and prolonged reduction in tumour blood flow as
measured by laser Doppler methods. This vasoactive effect
argues against the use of DiOC7(3) as the first marker in a
double staining regimen.
We have employed DiOC7(3), in a double staining
protocol together with Hoechst 33342, to detect regions of
transient perfusion in murine tumours. Administration of
DiOC7(3) 20min after Hoechst injection revealed regions of
tumour vasculature with unmatched staining patterns
indicative of transient vessel shutdown (Trotter et al., 1989).
Approximately equal numbers of vessels opened (DiOC7(3)
staining only) and closed (Hoechst 33342 staining only)
during the interval between stain injections (unpublished
results). This suggests that administration of DiOC7(3), and
the resultant transient reduction in tumour blood flow, is not
responsible for the staining mismatch observed.
In summary, the carbocyanine derivative DiOC7(3) can be
used to identify functional vasculature in experimental
tumours. Like Hoechst 33342, the dye rapidly enters cells
adjacent to the blood supply and penetrates slowly into
tumour parenchyma allowing identification of the
vasculature using fluorescence microscopy. The different
fluorescence excitation and emission properties of DiOC7(3)
and Hoechst 33342 permit discrimination of the stains in
tissue sections and thus the stains can be administered
sequentially to detect regions of transient perfusion in
murine tumours.
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